Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Therapeutic Delivery|September 26, 2017
Alginate-combined cholic acid increased insulin secretion of microencapsulated mouse cloned pancreatic β cellsArmin Mooranian, Rebecca Negrulj, Ryu Takechi, et al.
Journal of Microencapsulation|July 21, 2015
Novel chenodeoxycholic acid-sodium alginate matrix in the microencapsulation of the potential antidiabetic drug, probucol. An in vitro studyArmin Mooranian, Rebecca Negrulj, Momir Mikov, et al.
Drug Design, Development and Therapy|October 11, 2014
An optimized probucol microencapsulated formulation integrating a secondary bile acid (deoxycholic acid) as a permeation enhancerArmin Mooranian, Rebecca Negrulj, Nigel Chen-Tan, et al.
Artificial Cells, Nanomedicine, and Biotechnology|October 31, 2014
Advanced bile acid-based multi-compartmental microencapsulated pancreatic β-cells integrating a polyelectrolyte-bile acid formulation, for diabetes treatmentArmin Mooranian, Rebecca Negrulj, Nigel Chen-Tan, et al.
Journal of Microencapsulation|September 30, 2014
Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatmentArmin Mooranian, Rebecca Negrulj, Hesham S Al-Sallami, et al.
Artificial Cells, Nanomedicine, and Biotechnology|March 27, 2015
Swelling, mechanical strength, and release properties of probucol microcapsules with and without a bile acid, and their potential oral delivery in diabetesRebecca Negrulj, Armin Mooranian, Nigel Chen-Tan, et al.
Pageof 3